Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of PET/ CT in the 68Ga-NODAGA-RGD for the Evaluation of the Tumoral Neoangiogenesis

NCT02666547 is registered in ClinicalTrials.gov with University of Lausanne Hospitals as lead sponsor.

NCT NCT02666547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02666547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of PET/ CT in the 68Ga-NODAGA-RGD for the Evaluation of the Tumoral Neoangiogenesis
Lead sponsor
University of Lausanne Hospitals
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2014
Completion date
September 30, 2023
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pathological angiogenesis